nes that influence how the skin responds to procedural stress at a structural level. This innovation reflects our continued commitment to developing science-driven solutions that not only aid in procedural outcomes, but also support a more resilient skin recovery.”



ALAN D. WIDGEROW, MBBCH, MMED, FCS, FACS

CHIEF SCIENTIFIC OFFICER, GALDERMA

HEAD, SKIN SCIENCE CENTER FOR INNOVATION










Peer-reviewed clinical studies support the use of Regenerating Skin Nectar with TriHex+™ as a foundational periprocedural product. In a randomized, doubleblind facelift preconditioning study, 100% of patients showed visible improvements in key extracellular matrix (ECM) markers—including collagen, elastin, and highmolecularweight HA—alongside reductions in solar elastosis and a stronger, more defined DEJ.2The improvement in DEJ d
=*=*=*=*=*=
当前为第5/11页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页